According to a large amount of literature, there are 120 million people in China who are hepatitis B carriers. However, they always have some worries and often have the question “Do I become a hepatitis B patient and will my hepatitis B virus turn negative? They often have the question, “Do I become a hepatitis B patient? First of all, we can say for sure that it is possible for hepatitis B carriers to develop into hepatitis B patients, because most chronic hepatitis B patients are transformed from hepatitis B carriers. However, hepatitis B carriers do not have to worry about this, because only a small percentage of hepatitis B carriers will “become” hepatitis B patients each year, according to statistics, the country’s 120 million hepatitis B carriers each year, only 0.25%-0.4% of patients will become hepatitis B patients, and The vast majority of hepatitis B carriers will not become hepatitis B patients. What should I do once I become a hepatitis B carrier? Experts believe that hepatitis B carriers should face reality, maintain a balanced and optimistic attitude, and pay attention to health care, such as not drinking alcohol, living a regular life, and not overworking. What’s more, don’t hear rumors that any partial or secret prescription can cure, don’t believe in the overwhelming false advertisements, abuse and indiscriminate use of drugs lead to the destruction of immune function in the body, increase the burden on the liver and damage liver function. According to current observations, the prognosis of most hepatitis B virus carriers is good, and they may carry the virus for life, and a few may “naturally turn negative”. Regarding the natural reversion rate of hepatitis B carriers, our survey shows that it is about 3%, and it can reach about 6% with the increase of age. However, the natural reversion rate of hepatitis B virus carriers among Americans is very high. 454 cases of hepatitis B virus carriers have been followed for 51-54 months, and the reversion rate is 13%. It has also been reported that 90% of patients infected with hepatitis B virus at birth and become hepatitis B carriers will be spontaneously reverted by the age of 59 years without developing any disease in between. Of course, not all hepatitis B carriers have a good prognosis, and studies in China have shown that 70-80% of hepatitis B carriers may have “mild” liver lesions, and even some “hepatitis B carriers” are not really hepatitis B carriers. The “hepatitis B virus carriers” are not really carriers, but may be patients with asymptomatic or asymptomatic hepatitis, or even patients with cirrhosis. Therefore, hepatitis B virus carriers should also be taken seriously, experts believe that hepatitis B virus carriers should regularly go to regular hospitals to draw blood to check liver function and viral replication indicators, and ultrasound, and if necessary, liver puncture biopsy, as well as early detection of changes in the condition. Hepatitis B virus carriers and hepatitis B patients must pay attention to the “three elements” in life: one, is not to strain. Including moderate and heavy physical labor, strenuous sports, long nights and increased psychological stress, high mental tension, etc.; Second, is not to drink. Including liquor, red wine, beer and foreign wine, etc.; Third, can not be indiscriminate use of drugs. One of them is not to use the so-called “liver protection, virus removal” drugs, according to liver disease expert research reports, it is confirmed that the role of liver Chinese medicine with a bright ensure that only licorice, anti-fibrosis effect of Chinese medicine is salvia, there is an anti-hepatitis B virus effect of Chinese medicine only bitter ginseng and leaves under the beads of the preparation, but the clinical efficacy and mechanism of action However, the clinical efficacy and mechanism of action need to be studied in depth. Secondly, when suffering from other diseases, you must tell your doctor that your “liver is not good and easily injured” and ask him/her to try to choose drugs that are not harmful to the liver. Most people with hepatitis B “major tri-positive” and normal liver function are in a state of immune tolerance, which means that the virus and the body are in a “peaceful coexistence” stage. Doctors advocate that patients at this stage should be followed up regularly, and once hepatitis activity is detected (the indicator is elevated transaminases), antiviral treatment can be considered. Our hepatitis antiviral treatment program was developed last year based on the reference of the European Society of Liver Diseases and the Asia Pacific Society of Liver Diseases for anti-Hepatitis B virus treatment. The first choice is anti-hepatitis B virus treatment with interferon, which is relatively effective for people with short infection time, elevated transaminases, low viral titers, non-maternal-to-child transmission, and non-hepatitis B virus pre-C zone mutations. However, it is less effective for those with significant cirrhosis, jaundice, ascites, significantly low albumin, and those with diabetes and hyperthyroidism. Patients with chronic hepatitis B require antiviral therapy, and it is recommended that patients go to a liver disease specialist at a regular hospital, where the doctor will choose an appropriate regimen for treatment based on the results of tests related to liver function.